NCT05514496
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05514496
Title A Study of NX-019 in Patients With Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nalo Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center - Duarte Duarte California 91010 United States Details
City of Hope - Seacliff Huntington Beach California 92648 United States Details
City of Hope Orange County Lennar Foundation Cancer Center Irvine California 92618 United States Details
HealthPartners Frauenshuh Cancer Center Saint Louis Park Minnesota 55426 United States Details
HealthPartners Cancer Center at Regions Hospital Saint Paul Minnesota 55101 United States Details
University Of Virginia Comprehensive Cancer Center Charlottesville Virginia 22903 United States Details
NEXT Virginia Fairfax Virginia 22031 United States Details
Seoul National University Hospital Seoul 03080 South Korea Details
Severance Hospital Seoul 03722 South Korea Details
Asan Medical Center Seoul 05505 South Korea Details
Samsung Medical Center Seoul 06351 South Korea Details
National Taiwan University Cancer Center Taipei City Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field